Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
1 - 10 of 62
- IOF mandate Limburg Clinical Research Center (LCRC) 2024-2028From1 Jan 2024 → TodayFunding: IOF - mandates
- Structural funding of the LCRC centerFrom1 Jan 2024 → TodayFunding: BOF - research organisations
- Return to work through primary care: The development of a toolkit for general practitionersFrom1 Jan 2024 → TodayFunding: Department of Economy, Science and Innovation
- Donation agreement between Hasselt University, Mylan EPD BV and Noorderhart vzw regarding UMSC.From20 Dec 2022 → 20 Apr 2023Funding: Nonprofit institution or equivalents
- Integrated approach through first-line zones for reintegration into the labor market among the long-term sickFrom19 Dec 2022 → 18 Dec 2023Funding: Department of Economy, Science and Innovation
- Translational MS research UMSC.From29 Sep 2022 → 31 Dec 2022Funding: Industrial enterprises
- Unravelling the mechanism of single time vaccination strategy (SinTimVaS)From21 Feb 2022 → 31 Dec 2022Funding: BOF - projects
- NEURONET - Phase IIIFrom1 Feb 2022 → TodayFunding: BOF - Methusalem
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- DigiPath: The introduction of digital pathology in LimburgFrom16 Dec 2021 → TodayFunding: Provinces, Own budget, for example: patrimony, inscription fees, gifts
Publications
151 - 158 of 158
- Muscle fatigue resistance during experimental autoimmune encephalomyelitis in rats(2008)
Authors: Bert O. Eijnde, Tom Brockmans, Geert ALDERS, Jerome HENDRIKS, Piet STINISSEN
Pages: S121 - S121 - Natural naive regulatory T cell development and function are disturbed in multiple sclerosis patients(2008)
Authors: Koen VENKEN, Niels HELLINGS, Tom BROEKMANS, Karen HENSEN, Jean-Luc RUMMENS, Piet STINISSEN
Pages: 214 - 214 - Autoantibody profiling in multiple sclerosis: Further characterization of novel antigenic candidates(2008)
Authors: Veerle SOMERS, Klaartje SOMERS, Cindy GOVARTS, Raymond Hupperts, Rob MEDAER, Piet STINISSEN
Pages: 164 - 165 - Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3(2008)
Authors: Leen SLAETS, Debora DUMONT, Joris VANDERLOCHT, Jean-Paul NOBEN, P. Leprince, Johan ROBBEN, Jerome HENDRIKS, Piet STINISSEN, Niels HELLINGS
Pages: 1237 - 1247 - Neuroprotective and immunomodulatory effects of leukemia inhibitory factor during neuroinflammatory responses in multiple sclerosis(2008)
Authors: Leen SLAETS, Jerome HENDRIKS, Sofie CARMANS, Piet STINISSEN, Niels HELLINGS
Pages: 248 - 248 - Characterizing autoantibodies in multiple sclerosis by B cell immortalization(2008)
Authors: Judith FRAUSSEN, Pilar Martinez-Martinez, Marc DE BAETS, Anton Van Diepen, Els Meulemans, Piet STINISSEN, Veerle SOMERS
Pages: 183 - 184 - Study of CD4+CD25+FOXP3+ regulatory T cells in patients with multiple sclerosis(2008)
Authors: Koen VENKEN, Piet STINISSEN
- The central nervous system is still susceptible to the infiltration of myelin reactive T cells during the recovery phase of experimental autoimmune encephalomyelitis(2008)
Authors: Kurt BAETEN, Jerome HENDRIKS, Niels HELLINGS, Bieke BROUX, Jan GELAN, Peter ADRIAENSENS, Piet STINISSEN
Pages: 210 - 210
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)